Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 02, 2024	Feb. 25, 2023	Mar. 02, 2024	Feb. 25, 2023
Operating activities:
Net income	$ 750	$ 6,340	$ 180	$ 18,213
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	1,104	912	3,218	2,688
Inventory provisions	173	115	450	310
Share-based compensation expense	279	206	1,045	730
Loss (gain) on disposal of assets	0	13	70	(12)
Deferred income taxes	(4)	(1)	42	27
Change in assets and liabilities:
Accounts receivable	(5,254)	(7,189)	998	(12,694)
Inventories	3,974	(3,638)	(2,246)	(21,764)
Prepaid expenses and other assets	151	(153)	(58)	(578)
Accounts payable	(4,072)	(12)	(5,204)	784
Accrued liabilities	247	(661)	625	486
Other	121	(192)	164	397
Net cash used in operating activities	(2,531)	(4,260)	(716)	(11,413)
Investing activities:
Capital expenditures	(401)	(2,230)	(3,057)	(4,973)
Proceeds from maturity of investments	0	5,000	0	5,000
Proceeds from sale of property, plant & equipment	0	0	0	193
Net cash (used in) provided by investing activities	(401)	2,770	(3,057)	220
Financing activities:
Proceeds from issuance of common stock	0	511	342	3,413
Cash dividends paid on Common and Class B Common shares	(844)	(834)	(2,532)	(2,484)
Proceeds from short-term borrowing	3,744	0	3,744	0
Repayment of short-term borrowing	(3,744)	0	(3,744)	0
Other	0	0	(119)	(69)
Net cash (used in) provided by financing activities	(844)	(323)	(2,309)	860
Effect of exchange rate changes on cash and cash equivalents	(113)	352	(19)	(517)
Decrease in cash and cash equivalents	(3,889)	(1,461)	(6,101)	(10,850)
Cash and cash equivalents at beginning of period	22,769	26,106	24,981	35,495
Cash and cash equivalents at end of period	$ 18,880	$ 24,645	$ 18,880	$ 24,645